• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

vaccines

vaccine sales
Favicon Fierce Biotech

Valneva to lay off up to 15%, faces tough travel vaccine market

Valneva is planning to shrink its headcount by up to 15% as the French vaccine developer continues to seek ways to cut costs.
James Waldron May 13, 2026 8:35am
Robert Malone

CDC's vaccine advisory panel isn't being disbanded, for now

Mar 20, 2026 11:20am
Albert Bourla Pfizer CEO Bourla

Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad

Mar 3, 2026 4:58pm
HHS headquarters as seen on April 02 2025

Kennedy adds 2 new ACIP members ahead of March meeting

Mar 2, 2026 11:44am
reducing people on team

Merck, working through Gardasil demand woes, cuts jobs in N.C.

Feb 27, 2026 3:00pm
Merck

Merck splits human pharma business, establishing oncology unit

Feb 23, 2026 10:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings